Skip to main content
C

China Health Group Inc. — Investor Relations & Filings

Ticker · 8225 ISIN · KYG2117N1088 LEI · 254900PWX6498SJFLW25 HKEX Human health and social work activities
Open in API
Filings indexed 992 across all filing types
Latest filing 2025-12-02 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 8225

About China Health Group Inc.

http://www.chgi.net

China Health Group Inc. is an integrated healthcare platform providing solutions to pharmaceutical enterprises and medical institutions, driven by Real-World Study (RWS), Real-World Data (RWD), and Artificial Intelligence (AI). The company's core business encompasses four synergistic segments: Clinical Research and Product Promotion (CRSO), Hospital Operation and Management, Specialty Departments and Telemedicine, and Rehabilitation and Medical Tourism. Services include RWS-driven clinical research, scientific promotion, drug formulation and Active Pharmaceutical Ingredient (API) development, and technology transfer. The company also specializes in managing hospitals and internet medical facilities, developing research-oriented specialty services (e.g., mental rehabilitation, chronic disease prevention), and offering medical tourism projects. It provides full-chain support from R&D to clinical trials and registration for a global client base, including major international pharmaceutical companies.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. As it is a recurring regulatory filing mandated by the Exchange Listing Rules and does not fit into specific categories like 'Share Issue' (which would be a specific event) or 'Annual Report', it is best classified as a Regulatory Filing (RNS).
2025-12-02 English
Voluntary Announcement
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement issued by China Health Group Inc. in response to an inquiry letter from the Stock Exchange of Hong Kong regarding the recovery progress of trade receivables. It details specific collection efforts, legal actions, and internal management changes. Since it does not fit into specific categories like financial reports, dividends, or director dealings, and serves as a general regulatory disclosure to the market, it is classified as a Regulatory Filing (RNS).
2025-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Share Issue/Capital Change Classification · 1% confidence The document is HKEX Form FF301 “Monthly Return for Equity Issuer…and Hong Kong Depositary Receipts under Chapter 19B,” which reports detailed movements in authorized/issued share capital, share options, warrants, convertibles, etc. It is not an AGM pack, earnings announcement, or board change notice—it’s a periodic regulatory filing concerning equity capital movements. This fits the “Share Issue/Capital Change (SHA)” category (announcements regarding new share issues, capital structure movements). Therefore, the appropriate classification is SHA.
2025-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change Classification · 1% confidence The document is the HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts,” detailing movements in authorized share capital, issued shares, share options, etc. It is a regulatory filing about capital structure changes rather than an annual or interim report, earnings release, or management commentary. The content directly concerns share capital movements (new issues, options, treasury shares), so it aligns with the Share Issue/Capital Change category (SHA).
2025-10-08 English
APPOINTMENT OF AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement by China Health Group Inc. regarding the appointment of Mr. Raymond Guo as an authorised representative. It details a change in board/management roles rather than financial results, voting, or report publication. This is clearly an announcement of a board/management change, matching the ‘Board/Management Information’ category (MANG).
2025-09-25 English
INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT' for the six months ended 30 June 2025. It contains comprehensive unaudited financial statements, including the Statement of Profit or Loss, Statement of Financial Position, Cash Flow Statement, and Statement of Changes in Equity, along with detailed notes to the financial statements. It also includes a 'Management Discussion and Analysis' section. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2025
2025-09-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.